Overview

A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer

Status:
Not yet recruiting

Trial end date:
2029-05-01

Target enrollment:

Participant gender:

Summary

This study is to evaluate the efficacy and safety of AK104 plus concurrent chemoradiotherapy compared to placebo plus concurrent chemoradiotherapy in participants with locally advanced cervical cancer

Phase:

Phase 3

Details

Lead Sponsor:

Akeso

Treatments:

Cisplatin